Dechra Pharmaceuticals (DPH)

 

Latest News

Total Voting Rights

RNS Number: 1204V Dechra Pharmaceuticals PLC 31 October 2017 31 October 2017 Dechra Pharmaceuticals PLC (Dechra or the Company) LEI: 213800J4UVB5OWG8VX82 Total Voting Rights In conformity with DTR 5.6.1R, the Company notifies the market of the following: As at the date of this announcement, the Company's issued share capital consists of 93,415,750...

Result of AGM - 20 October 2017

RNS Number: 2365U Dechra Pharmaceuticals PLC 20 October 2017 Date: 20 October 2017 Dechra Pharmaceuticals PLC Results of Annual General Meeting (AGM) AGM Meeting Date: 1pm on 20 October 2017 Issued Share Capital at meeting date: 93,415,750 Number of shareholders in attendance: 12 All resolutions were passed on a show of hands. Details of the proxy v...

Top smaller companies thriving overseas

Two top fund managers tell David Brenchley about their favourite small and mid-cap companies as they rotate out of UK...

Dechra sees continued growth across all markets

Dechra Pharmaceuticals' performance in the first quarter was in line with management expectations, with continued grow...

All News

DateHeadlineSource
31-10-17Total Voting RightsRNS
20-10-17Result of AGM - 20 October 2017RNS
20-10-17Top smaller companies thriving overseasInteractive Investor
20-10-17Dechra sees continued growth across all markets StockMarketWire
20-10-17Pre Annual General Meeting StatementRNS
18-10-17Holding(s) in CompanyRNS
12-10-17Director/PDMR ShareholdingRNS
12-10-17Additional ListingRNS
04-10-17Holding(s) in CompanyRNS
02-10-17Total Voting RightsRNS
20-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
20-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
20-09-17Director/PDMR ShareholdingRNS
19-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
19-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
19-09-17Director/PDMR ShareholdingRNS
19-09-17Annual Financial ReportRNS
15-09-17BLOCK LISTING SIX MONTHLY RETURNRNS
08-09-17Broker Forecast - Cantor Fitzgerald issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
06-09-17Additional ListingRNS
05-09-17Broker Forecast - Jefferies International issues a broker note on Dechra Pharmaceuticals PLCStockMarketWire
05-09-17Availability of 2017 Annual Report and AccountsRNS
04-09-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
04-09-17Director/PDMR ShareholdingRNS
04-09-17Preliminary Results Announcement -year end 30.6.17RNS
31-08-17Total Voting RightsRNS
17-08-17Holding(s) in CompanyRNS
11-08-17Expert picks these winning shares for the Brexit eraMoney Observer
31-07-17Total Voting RightsRNS
25-07-17Holding(s) in CompanyRNS
06-07-17Dechra growth driven by core portfolio StockMarketWire
06-07-17Trading Update & Notice of Annual ResultsRNS
30-06-17Total Voting RightsRNS
22-06-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire
22-06-17Director/PDMR ShareholdingRNS
31-05-17Total Voting RightsRNS
18-05-17Holding(s) in CompanyRNS
03-05-17Director/PDMR ShareholdingRNS
28-04-17Total Voting RightsRNS
24-04-17Director Deals - Dechra Pharmaceuticals PLC (DPH)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:DPH Editorial
  • Regulatory news feed for LSE:DPH Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account